Table 1. Clinical characteristics of study participants.
| SUB ID | Age | Gender | Main Symptom | Disease Duration (yrs) |
UPDRS-III OFF/ON Levodopa | Levodopa equivalent dose (mg/d) | DBS Lead |
|---|---|---|---|---|---|---|---|
| 1 | 59 | M | tremor, bradykinesia, dyskinesia | 7 | 53/18 | 1195 | Boston Scientific DB-2202 |
| 2 | 64 | F | rigidity, tremor, FOG | 16 | 66/36 | 1628 | Boston Scientific DB-2202 |
| 3 | 59 | M | fluctuations, tremor | 14 | 36/8 | 1062 | Medtronic3389 |
| 4 | 56 | M | fluctuations, dyskinesia | 7 | 42/26 | 1365 | Medtronic3389 |
| 5 | 62 | M | tremor, rigidity, dyskinesia, mild FOG | 12 | 59/15 | 1000 | Medtronic3389 |
| 6 | 71 | M | tremor, FOG | 15 | 36/18 | 785 | Boston Scientific DB-2202 |
| 7 | 61 | M | rigidity | 9 | 33/11 | 1293 | Medtronic3389 |
| 8 | 59 | M | tremor, mild FOG |
10 | 28/8 | 1010 | Boston Scientific DB-2202 |
M, male; F, female; FOG, freezing of gait.